Variables that experienced a fragile association with a sustained virologic response in the initial logistic-regression model were excluded from the ultimate model. Results Characteristics of the Patients Of 388 patients screened, 334 were randomly assigned to cure group and 323 received study medication . The characteristics of the treatment groups were identical at baseline . Virologic Responses during the Treatment Period Table 2Table 2Undetectable HCV RNA Levels during and after Treatment, According to Treatment Group. Displays the proportion of individuals with undetectable HCV RNA at weeks 4, 12, and 24 through the treatment period in addition to 24 weeks after completion of planned treatment in the four groups.Alvarez, PharmD, BCPS, FAPhA,of Lake Forest, CA, as 2016–2017 APhA President-elect. Alvarez shall succeed Jean-Venable Kelly R. Goode, of Richmond, VA, to the working workplace of APhA President on March 27, 2017, at the conclusion of the 2017 APhA Annual Achieving & Exposition in San Francisco. Also elected to serve a three-yr term on APhA’s Board of Trustees, beginning in March 2016, areDaniel Zlott, PharmD, BCOP,of Lovettsville, VA, andDaniel E. Buffington, PharmD, MBA, FAPhA,of Tampa, FL. Elected mainly because 2016–2017 Honorary President wasJean Paul Gagnon, PhD,of Pittstown, NJ. All officers will be set up at the 163rd APhA Annual Achieving & Exposition in Baltimore, March 4–7, 2016. Nancy A. Alvarez, PharmD, BCPS, FAPhA,can be Assistant Dean, Experiential Education and Continuing Professional Development, and Associate Professor at Chapman University School of Pharmacy.